Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.98M | 546.00K | -7.05M | 850.00K | 10.22M | 1.21M |
Gross Profit | -374.00K | 292.00K | -7.05M | 850.00K | 10.22M | 1.21M |
EBITDA | -2.90M | -1.62M | -9.37M | -1.74M | 8.66M | 98.00K |
Net Income | -3.46M | -1.76M | -9.91M | -3.54M | 8.66M | 88.00K |
Balance Sheet | ||||||
Total Assets | 9.17M | 7.46M | 8.25M | 16.62M | 17.69M | 9.08M |
Cash, Cash Equivalents and Short-Term Investments | 3.87M | 2.13M | 495.00K | 1.21M | 3.53M | 5.56M |
Total Debt | 214.00K | 266.00K | 127.00K | 260.00K | 351.00K | 438.00K |
Total Liabilities | 2.69M | 3.35M | 2.92M | 1.63M | 1.04M | 1.06M |
Stockholders Equity | 6.55M | 3.95M | 5.33M | 14.99M | 16.65M | 8.03M |
Cash Flow | ||||||
Free Cash Flow | -1.38M | -1.23M | -1.26M | -829.00K | -256.00K | -280.00K |
Operating Cash Flow | -1.38M | -1.23M | -1.26M | -829.00K | -253.00K | -266.00K |
Investing Cash Flow | 395.00K | 780.00K | -105.00K | -661.00K | -1.80M | 110.00K |
Financing Cash Flow | 3.65M | 2.60M | 1.18M | 0.00 | -1.00K | -384.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | $11.80B | 6.39 | 17.69% | 0.63% | 23.19% | -22.42% | |
82 Outperform | $2.45B | 6.53 | 14.87% | ― | 28.86% | -11.22% | |
66 Neutral | $2.14B | 20.40 | 8.06% | ― | -4.56% | -55.48% | |
66 Neutral | $441.50M | 11.79 | 6.73% | ― | 2.18% | -41.11% | |
53 Neutral | $207.48M | -1.05 | ― | ― | -72.34% | -289.97% | |
48 Neutral | $14.97M | ― | -58.30% | ― | ― | 78.09% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
On August 28, 2025, Oxbridge Re Holdings held an Extraordinary General Meeting where shareholders approved significant changes to the company’s share capital and governance documents. The authorized share capital was increased from 50 million to 500 million shares, reflecting a substantial expansion in the company’s equity capacity. Additionally, the shareholders approved the 2025 Omnibus Incentive Plan and amendments to the company’s Memorandum and Articles of Association, which are expected to enhance the company’s operational flexibility and strategic positioning.
On July 9, 2025, Oxbridge Re Holdings Limited entered into an Equity Distribution Agreement with Maxim Group LLC to offer and sell up to $5 million of its ordinary shares. The agreement allows for ‘at-the-market’ offerings and replaces a prior agreement from 2022. The company plans to use the proceeds for general corporate purposes, including funding its reinsurance operations, and will invest the proceeds in short-term, investment-grade instruments or hold them as cash.